Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
December 8, 2006

Andrew von Eschenbach Voted Chief of FDA

  • The Senate voted Andrew von Eschenbach, M.D., chief of the FDA. Senators supported his nomination by a vote of 80 to 11. This decision comes after slightly over a year of Dr. von Eschenbach serving as acting head of the FDA. During that time he erased a major obstacle to his confirmation by allowing access to Plan B, the morning after pill, without a prescription.

    “It is critical that the FDA again be the gold standard of drug approval,” Senator Hillary Clinton in her official statement. “By making a long overdue decision on Plan B, Dr. von Eshenbach showed encouraging signs that he will take seriously the FDA’s responsibility to put science over ideology."

  • You’re all set! Thank you for subscribing to GEN Highlights.